<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01450956</url>
  </required_header>
  <id_info>
    <org_study_id>XJXZ2011-010</org_study_id>
    <nct_id>NCT01450956</nct_id>
  </id_info>
  <brief_title>The Protective Effects of Sevoflurane in Pediatric Cardiac Surgery</brief_title>
  <official_title>The Protective Effects of Sevoflurane Application During CPB on Pediatric Patients Underwent Cardiac Surgery: a Randomized, Controlled, Blinded Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During repair of a congenital heart defect the child is exposed to myocardial hypoxia. Recent
      studies have suggested that the paediatric myocardium is more sensitive to hypoxia and
      cardioplegic arrest than the adult. The protective effect of halogenated agents on ischaemia
      and reperfusion injury has been investigated widely in adults. The investigators hypothesis
      that sevoflurane applied during cardiopulmonary bypass might afford better myocardial
      protection during paediatric cardiac surgery.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">January 2012</completion_date>
  <primary_completion_date type="Anticipated">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>all cause mortality</measure>
    <time_frame>within the first 30 days (plus or minus 3 days) after surgery</time_frame>
    <description>All cause mortality after the cardaic surgery, patients will be followed up for 30 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum cTnI concentrations</measure>
    <time_frame>48 h after the surgery</time_frame>
    <description>serial serum cTnI concentrations will be determined to whether sevoflurane application during CPB will decrease the cTnI release after operation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Congenital Heart Diseases</condition>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive 2% sevoflurane via oxygenator during CPB</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will receive only oxygen and air through oxygenator</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Sevoflurane will be given at a concentration of 2% through oxygenator during CPB</description>
    <arm_group_label>Sevoflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Patients will receive only oxygen and air through oxygenator</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pediatric patients (body weight &lt; 10 kg)

          -  diagnosed with congenital heart diseases

          -  scheduled for repair operation with CPB

          -  in the Department of Cardiovascular Surgery, Xijing Hospital

        Exclusion Criteria:

          -  systemic infections

          -  other systemic diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>24 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhenxiao Jin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiovascular Surgery, Xijing Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhenxiao Jin, Ph.D</last_name>
    <phone>86-29-84771022</phone>
    <email>jinzx10262@yahoo.com.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Cardiovascular Surgery, Xijing Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhenxiao Jin, PhD</last_name>
      <phone>86-29-84771022</phone>
      <email>jinzx10262@yahoo.com.cn</email>
    </contact>
    <investigator>
      <last_name>Hongyan Xiong, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2011</study_first_submitted>
  <study_first_submitted_qc>October 12, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2011</study_first_posted>
  <last_update_submitted>November 24, 2011</last_update_submitted>
  <last_update_submitted_qc>November 24, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 28, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>congenital heart diseases</keyword>
  <keyword>cardiopulmonary bypass</keyword>
  <keyword>Pediatric</keyword>
  <keyword>sevoflurane</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>November 19, 2013</submitted>
    <returned>January 7, 2014</returned>
    <submitted>August 18, 2014</submitted>
    <returned>August 19, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

